Study Design
Subject Type
Human
Trial Design
Double-Blind, Randomised, Controlled
Trial Duration
21 days
Participants
16
Age Range
40-60 years
Efficacy
Intervention(s) Outcome
Skin Thickness
Sign in to read for free
Skin Thickness
Sign in to read for free
Skin Thickness
Sign in to read for free
Skin Thickness
Sign in to read for free
Skin Thickness
Sign in to read for free
Skin Thickness
Sign in to read for free
Skin Thickness
Sign in to read for free
Skin Thickness
Sign in to read for free
Mechanisms
Intervention(s) Outcome
CRABP2
Sign in to read for free
CRABP2
Sign in to read for free
CRABP2
Sign in to read for free
CRABP2
Sign in to read for free
CRABP2
Sign in to read for free
CRABP2
Sign in to read for free
CRABP2
Sign in to read for free
CRABP2
Sign in to read for free
CRABP2
Sign in to read for free
CRABP2
Sign in to read for free
Collagen
Sign in to read for free
Collagen
Sign in to read for free
Collagen
Sign in to read for free
Collagen
Sign in to read for free
Keratin
Sign in to read for free
Keratin
Sign in to read for free
Keratin
Sign in to read for free
Keratin
Sign in to read for free
Keratin
Sign in to read for free
Keratin
Sign in to read for free
Keratin
Sign in to read for free
Keratin
Sign in to read for free
Keratinocyte Proliferation
Sign in to read for free
Keratinocyte Proliferation
Sign in to read for free
Keratinocyte Proliferation
Sign in to read for free
Keratinocyte Proliferation
Sign in to read for free
Loricrin
Sign in to read for free
Loricrin
Sign in to read for free
Loricrin
Sign in to read for free
Loricrin
Sign in to read for free
Study Summary
Sign in to read for free